Li Yuan, Wu Xiao
Beijing Tongren Eye Centre, Affiliated Beijing Tongren Hospital, Capital University of Medical Science, Beijing 100730, China.
Zhonghua Yan Ke Za Zhi. 2008 Nov;44(11):967-71.
To observe the effect of botulinum toxin A (BTXA) management in childhood with intermittent exotropia.
A prospective non-random clinical study was performed in 60 children aged from 4 to 12 years, who diagnosed to be intermittent exotropia. Patients were divided into surgery groups and BTXA group according to the intention of patient's parent. The recession of bilateral rectus muscle was performed in 30 patients in surgery group. BTXA injection into bilateral rectus muscle was performed in 30 patients in BTXA group. Eye alignment and the binocular vision were evaluated 6 months after the treatments.
In BTXA group, the deviation was (-41.33 +/- 12.17)Delta (-30Delta to -75Delta) at the baseline, and (6.23 +/- 9.80)Delta (-30Delta to 0Delta) 6 month after BTXA injection. Among the patients, 7 cases were under-correct. In surgery group, the deviation was (-42.83 +/- 11.72)Delta (-25Delta to -80Delta) at the baseline, and (2.67 +/- 5.21)Delta (-15Delta to +15Delta) 6 months after surgery. Among these patients, 1 case was under-corrected, and 2 cases were overcorrected. The recovery rate was 76.67% and 90.00% respectively in BTXA and surgery group, and was no statistically significant difference these two groups (P = 0.177) and the recovery rate (chi2 = 0.42, P = 0.166). Some patients were found to have fusion and distance stereopsis re-built, while some others were found to have near stereopsis improvement in both groups.
BTXA injection is a rapid, less invasive and effective procedure for the intermittent exotropia.
观察A型肉毒杆菌毒素(BTXA)治疗儿童间歇性外斜视的效果。
对60例4至12岁诊断为间歇性外斜视的儿童进行前瞻性非随机临床研究。根据患儿家长的意愿将患者分为手术组和BTXA组。手术组30例患者行双侧直肌后徙术。BTXA组30例患者行双侧直肌BTXA注射。治疗6个月后评估眼位矫正情况和双眼视功能。
BTXA组基线时斜视度为(-41.33±12.17)三棱镜度(-30三棱镜度至-75三棱镜度),BTXA注射6个月后为(6.23±9.80)三棱镜度(-30三棱镜度至0三棱镜度)。其中7例矫正不足。手术组基线时斜视度为(-42.83±11.72)三棱镜度(-25三棱镜度至-80三棱镜度),术后6个月为(2.67±5.21)三棱镜度(-15三棱镜度至+15三棱镜度)。其中1例矫正不足,2例矫正过度。BTXA组和手术组的治愈率分别为76.67%和90.00%,两组间差异无统计学意义(P = 0.177),治愈率比较差异无统计学意义(χ2 = 0.42,P = 0.166)。两组均有部分患者融合功能和远距离立体视重建,部分患者近距离立体视改善。
BTXA注射治疗间歇性外斜视是一种快速、微创且有效的方法。